Ajanta Pharma
₹3,329-30.40 (-0.90%)as of 2026-10-16
- Market Cap
- ₹41,478Cr.
- P/E Ratio
- 36.5
- P/B Ratio
- 9.20
- EPS (TTM)
- ₹91.21
- Day Range
- ₹3,308.3 – ₹3,381
- Div Yield
- 0.96%
- ROCE
- 34.5%
- ROE
- 27.1%
52W Low: ₹2,38252W High: ₹3,796
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 13.0% a year over three years.
- Debt is 0.06× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Ajanta_Pharma — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 36.5P/E: 36.5 | P/B: 9.20Growth
GrowingSales CAGR — 3Y: 13% · 1Y: 20%Profitability
High MarginROCE: 34.5% | ROE: 27.1%Key Metrics
Valuation
PEG Ratio 1.52
Price / Sales 7.18x
Price / FCF 245.4x
Book Value ₹362
Margins & returns
Operating Margin 25%
Net Margin 19.6%
Return on Assets 18.8%